SUMMARY The monoclonal antibody RAP-5 generated against a synthetic peptide corresponding to amino acid positions 10-17 of the ras p21 protein was used in an immunohistochemical study of the expression of ras in normal, benign, and malignant breast epithelium in man. The staining intensity and intracellular distribution of RAP-5 was similar in the three epithelial populations and extended to other tissue elements including myoepithelial cells, smooth muscle, myelin, capillary endothelium, and stromal fibroblasts, as well as sebaceous glands and sweat glands overlying the breast. These results suggest that RAP-5 recognises a normal cellular component, the expression of which is not more enhanced in hyperplastic or neoplastic conditions. The detection of mutant forms of p21 exclusively expressed in malignant tumours requires that alternative reagents be developed. 
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At least 25 viral oncogenes with known cellular homologues have been described, and several of them are thought to have important roles in the initiation, promotion, or progression of tumours. 1 2 The cellular oncogenes most commonly implicated in many different malignancies in man belong to the c-ras gene family. Activation of ras genes is usually a consequence of structural rather than regulatory mutuations.3 Activated cellular Kirsten sarcoma virus oncogene (c-Ki-ras) has been detected in lung, colon, and ovarian tumours; cellular Harvey sarcoma virus oncogene (c-Ha-ras) At the tissue level DNA and RNA hybridisation is presently difficult to achieve with fixed embedded pathological specimens, not least on account of the low copy number of the genes and message. Furthermore, hybridisation techniques provide no information on the ultimate concentration of a given gene product or its cellular distribution. Accordingly, considerable effort has recently been devoted to the development of monoclonal antibodies against oncogene products and to their immunohistochemical application on pathological material. One such series of reagents has been generated against synthetic peptides corresponding to amino acid positions 10-17 of the ras p21 protein."3 The reactivity of one of these antibodies (RAP-5) with normal, benign, and malignant epithelium of the human breast is the subject of this study. We show that, in common with reagents reactive with other ras p21 epitopes, the product detected by RAP-5 is a normal component of several cell types and is neither limited to normal epithelial cells undergoing proliferation nor to their neoplastic counterparts.
Material and methods
Human breast tissue samples were obtained from the surgical pathology files of the histopathology department at this hospital. They had been fixed in 
Results
The results of staining of the "normal", benign, and malignant breast tissue samples are shown in Table 1 . The staining intensity was graded from weak (+ /-) to intense (+ + +).
NORMAL BREAST
The two cases of "normal" breast examined showed intense staining of the glandular epithelium. Both lobules and ducts were positive and the stain was generally uniformly distributed throughout the cytoplasm (Fig. 1) . Areas of normal breast tissue adjacent to carcinomas showed a similar staining reaction. (Fig. 2) .
FIBROADENOMA
The epithelium in the fibroadenoma cases gave a consistent staining pattern similar to that observed in other benign breast conditions. The ductules gave a uniform cytoplasmic staining reaction (Fig. 3) . Tables 2 and 3. There was a gradual decrease in the intensity of stain with dilution on both benign and malignant breast lesions.
In addition to positive staining of epithelial cells with the RAP-5 monoclonal antibody, other tissue elements also stained. Myoepithelial cells gave variable staining, smooth muscle and myelin were positive in most cases (Fig. 6) , and capillary endothelium and stromal fibroblasts were positive in some cases. Sebaceous glands and sweat glands in the skin overlying the breast also showed positive staining with the RAP-5 antibody.
Discussion
The activity of cellular ras proto-oncogenes has hitherto been associated with cell growth and proliferation and in an activated form with oncogenesis. vX 'erg'Xi"' rasT24 in comparison with the normal Hu-ras"' peptide by solid phase radioimmunoassay, RAP-5 could not discriminate between Hu-ras gene products (Haras, Ki-ras, and N-ras) . The pattern of reactivity should, therefore, be regarded as "group specific" rather than "type specific", and the possibility of detecting mutant p21 by immunohistochemistry should be correspondingly diminished.
Less readily explained, however, is the finding of heterogenous ras p21 expression in most of the primary mammary carcinomas, contrasting with its virtual absence from fibroadenomous and fibrocystic disease.'3 These data suggest that ras p21 participates in the neoplastic transformation of mammary epithelium. In our hands dilutional analysis and comparison of staining intensities have consistently detected the product in normal and benign tissues, not only of breast as in the present study, but also in colorectal epithelium (unpublished data).
The numbers of specimens in the two studies (aggregate 98) are such that selection of material is unlikely to account for the differences. We therefore attribute the disparity to some hitherto unrecognised nuance of technique either at the level of tissue processing or storage, or both, or sensitivity of staining. Whatever the explanation, it seems that RAP-5, while undoubtedly of intrinsic interest for the study of ras gene translation systems, is of limited usefulness in routine immunopathology.
Other features of this study are that RAP-5 does not differentiate subpopulations of proliferating cells, nor cells with an increased propensity for metastasis. P21 is also reported to be membrane associated, so that the importance of the predominantly cytoplasmic staining we found is unclear.
One possibility is diffusion of the membrane associated protein into the cytoplasm as an artefact of the fixation process. There is even the possibility, however, not yet formally excluded, that the peptide sequence recognised by RAP-5 is unmasked at the tissue level in widely distributed proteins other than ras p21.
Our study compares with that of recent immunohistochemical experience in human colorectal neoplasia with another monoclonal antibody to ras p21 protein.'920 The monoclonal antibody Y13 259 is one of a series produced in rats bearing sarcomas induced by Harvey virus2' and reactive with p21 protein species encoded by both the Harvey and Kirsten strains of the virus. The close homology of the p21 products of viral and cellular ras genes is such that the proteins are identical in all but three of the 189 amino acid residues.22 Y13259 binds to a single protein band with an apparent molecular weight of 2lKd on sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) which is present in substantial quantities in ras transformed cells but at much lower levels in non-transformed cells. The pattern and intensity of ras p21 staining with this reagent, however, was comparable with that of colonic adenocarcinomas and normal mucosa,19 while adenomas reacted'more strongly.20 These results again differed from those obtained with the RAP series of monoclonal antibodies'3 23 on colorectal tissue, which found that ras p21 expression correlated with the depth of invasion of colonic carcinoma within the bowel wall.
In conclusion, the inability of RAP-5 to distinguish between p21 proteins neither confirms nor denies the role of ras genes in mammary carcinogenesis in man. By the same evidence considerable overproduction of the normal p21 product does not seem to occur in this disease. Slamon et al6 and Tatosyan et a!24 showed that more than one oncogene may be activated in tumours arising from the same site. Different patterns of oncogene activation in tumours, consistent with current views on multiple carcinogenesis,25 may conceivably be of different clinical importance, and such correlates may eventually be clarified by comparing oncogene activation profiles with clinical outcome. Antibodies to oncogene products might have a role in such studies, provided reagents of appropriate specificity at the tissue level could be generated. In situ hybridisation, or analysis of restriction fragment polymorphism of tumour DNA, however, might ultimately be more promising approaches. 
